Frank Milan Berger (June 25, 1913 - March 18, 2008) was a Czechoslovakian pharmacologist who discovered

meprobamate Meprobamate—marketed as Miltown by Wallace Laboratories and Equanil by Wyeth, among others—is a carbamate derivative used as an anxiolytic drug. It was the best-selling minor tranquilizer for a time, but has largely been replaced by the benz ...

carisoprodol Carisoprodol, sold under the brand name Soma among others, is a medication used for musculoskeletal pain. Use is only approved for up to three weeks. Effects generally begin within half an hour and last for up to six hours. It is taken orally. ...

, and

felbamate Felbamate (marketed under the brand name Felbatol by MedPointe) is an anticonvulsant used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associa ...

, while working at

Wallace Laboratories Carter-Wallace was a personal care company headquartered in New York City. The company was formed by the merger of Carter Products and Wallace Laboratories. The company has a research facility in Cranbury, New Jersey. History The company was form ...

. He also discovered the 'tranquilising' effects of

mephenesin Mephenesin (INN) is a centrally acting muscle relaxant. It can be used as an antidote for strychnine poisoning. Mephenesin however presents with the major drawbacks of having a short duration of action and a much greater effect on the spinal cord ...

in rodents while working at a laboratory in the

United Kingdom The United Kingdom of Great Britain and Northern Ireland, commonly known as the United Kingdom (UK) or Britain, is a country in Europe, off the north-western coast of the continental mainland. It comprises England, Scotland, Wales and North ...

, and campaigned against the advertising of medications in the mass media.

References

{{DEFAULTSORT:Berger, Frank 1913 births 2008 deaths Scientists from Plzeň Czechoslovak pharmacologists Charles University alumni